Nautilus Biotechnology (NAUT) Capital Expenditures Growth (5y) (2025 - 2026)

Nautilus Biotechnology (NAUT) Capital Expenditures Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,094.26 Bn	68,093.97 Bn	-
2	Nanobiotix	1,939.09 Bn	1,939.02 Bn	-
3	Akari Therapeutics	1,132.35 Bn	1,132.35 Bn	-
4	BeOne Medicines	473.53 Bn	468.74 Bn	1.35 Bn
5	Vertex Pharmaceuticals	123.34 Bn	116.09 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.13 Bn	61.38 Bn	3.31 Bn
7	Belite Bio	62.96 Bn	62.96 Bn	-
8	Argenx Se	56.38 Bn	51.20 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.67 Bn	34.66 Bn	959.66 Mn
10	Nautilus Biotechnology	213.38 Mn	117.51 Mn	-

Download Data